BRPI0910854A2 - métodos de tratamento - Google Patents

métodos de tratamento

Info

Publication number: BRPI0910854A2
Authority: BR; Brazil
Prior art keywords: treatment methods; treatment; methods
Prior art date: 2008-03-28

Application number

BRPI0910854A

Other languages

English (en)

Inventor

Fredrick E Hargreave

Giampietro Ventresca

Original Assignee

Glaxosmithkline Llc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2008-03-28

Filing date

2009-03-27

Publication date

2015-10-06

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=41114741&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BRPI0910854(A2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2009-03-27 Application filed by Glaxosmithkline Llc filed Critical Glaxosmithkline Llc

2015-10-06 Publication of BRPI0910854A2 publication Critical patent/BRPI0910854A2/pt

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/24—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
- C07K16/244—Interleukins [IL]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
- A61K39/39533—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals
- A61K39/3955—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals against proteinaceous materials, e.g. enzymes, hormones, lymphokines
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/10—Anthelmintics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/10—Antioedematous agents; Diuretics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
- C07K14/54—Interleukins [IL]
- C07K14/5409—IL-5

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
Organic Chemistry (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Pulmonology (AREA)
Immunology (AREA)
Genetics & Genomics (AREA)
Biochemistry (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Molecular Biology (AREA)
Biophysics (AREA)
Hematology (AREA)
Tropical Medicine & Parasitology (AREA)
Diabetes (AREA)
Endocrinology (AREA)
Microbiology (AREA)
Epidemiology (AREA)
Mycology (AREA)
Neurology (AREA)
Nutrition Science (AREA)
Dermatology (AREA)
Heart & Thoracic Surgery (AREA)
Cardiology (AREA)
Physical Education & Sports Medicine (AREA)
Orthopedic Medicine & Surgery (AREA)
Otolaryngology (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Peptides Or Proteins (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

BRPI0910854A 2008-03-28 2009-03-27 métodos de tratamento BRPI0910854A2 (pt)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US4036308P	2008-03-28	2008-03-28
PCT/US2009/038509 WO2009120927A2 (en)	2008-03-28	2009-03-27	Methods of treatment

Publications (1)

Publication Number	Publication Date
BRPI0910854A2 true BRPI0910854A2 (pt)	2015-10-06

Family

ID=41114741

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
BRPI0910854A BRPI0910854A2 (pt)	2008-03-28	2009-03-27	métodos de tratamento

Country Status (14)

Country	Link
US (3)	US9834600B2 (pt)
EP (1)	EP2274009B1 (pt)
JP (4)	JP5917143B2 (pt)
KR (1)	KR20100134702A (pt)
CN (1)	CN102026660A (pt)
AU (1)	AU2009228163B2 (pt)
BR (1)	BRPI0910854A2 (pt)
CA (1)	CA2719786A1 (pt)
EA (1)	EA201071137A1 (pt)
ES (1)	ES2441945T3 (pt)
IL (1)	IL208354A0 (pt)
MX (1)	MX2010010667A (pt)
WO (1)	WO2009120927A2 (pt)
ZA (1)	ZA201006648B (pt)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JP2010521496A (ja)	2007-03-14	2010-06-24	ノップニューロサイエンシーズ、インク．	キラル精製置換ベンゾチアゾールジアミンの合成
US9834600B2 (en) *	2008-03-28	2017-12-05	Glaxosmithkline Llc	Methods of treatment of eosinophilic bronchitis with an anti-IL-5 antibody
US20110190356A1 (en)	2008-08-19	2011-08-04	Knopp Neurosciences Inc.	Compositions and Methods of Using (R)- Pramipexole
EP2600901B1 (en)	2010-08-06	2019-03-27	ModernaTX, Inc.	A pharmaceutical formulation comprising engineered nucleic acids and medical use thereof
CN104531812A (zh)	2010-10-01	2015-04-22	现代治疗公司	设计核酸及其使用方法
US8710200B2 (en)	2011-03-31	2014-04-29	Moderna Therapeutics, Inc.	Engineered nucleic acids encoding a modified erythropoietin and their expression
US9464124B2 (en)	2011-09-12	2016-10-11	Moderna Therapeutics, Inc.	Engineered nucleic acids and methods of use thereof
BR112014007852B1 (pt)	2011-10-03	2021-11-03	Moderna Therapeutics, Inc	Polinucleotídeo isolado modificado e composição farmacêutica
PL2791160T3 (pl)	2011-12-16	2022-06-20	Modernatx, Inc.	Kompozycje zmodyfikowanego mrna
US9512096B2 (en)	2011-12-22	2016-12-06	Knopp Biosciences, LLP	Synthesis of amine substituted 4,5,6,7-tetrahydrobenzothiazole compounds
US10501512B2 (en)	2012-04-02	2019-12-10	Modernatx, Inc.	Modified polynucleotides
US9572897B2 (en)	2012-04-02	2017-02-21	Modernatx, Inc.	Modified polynucleotides for the production of cytoplasmic and cytoskeletal proteins
HK1206779A1 (en)	2012-04-02	2016-01-15	Modernatx, Inc.	Modified polynucleotides for the production of nuclear proteins
US9283287B2 (en)	2012-04-02	2016-03-15	Moderna Therapeutics, Inc.	Modified polynucleotides for the production of nuclear proteins
DK2922554T3 (en)	2012-11-26	2022-05-23	Modernatx Inc	Terminalt modificeret rna
US9662313B2 (en)	2013-02-28	2017-05-30	Knopp Biosciences Llc	Compositions and methods for treating amyotrophic lateral sclerosis in responders
US8980864B2 (en)	2013-03-15	2015-03-17	Moderna Therapeutics, Inc.	Compositions and methods of altering cholesterol levels
ES3043076T3 (en)	2013-07-12	2025-11-24	Areteia Therapeutics Inc	Treating elevated levels of eosinophils and/or basophils
US9468630B2 (en)	2013-07-12	2016-10-18	Knopp Biosciences Llc	Compositions and methods for treating conditions related to increased eosinophils
US9763918B2 (en)	2013-08-13	2017-09-19	Knopp Biosciences Llc	Compositions and methods for treating chronic urticaria
EP3038467B1 (en)	2013-08-13	2020-07-29	Knopp Biosciences LLC	Compositions and methods for treating plasma cell disorders and b-cell prolymphocytic disorders
US10023626B2 (en)	2013-09-30	2018-07-17	Modernatx, Inc.	Polynucleotides encoding immune modulating polypeptides
WO2015051214A1 (en)	2013-10-03	2015-04-09	Moderna Therapeutics, Inc.	Polynucleotides encoding low density lipoprotein receptor
SI3191513T1 (sl) *	2014-09-08	2020-12-31	Cephalon, Inc.	Uporaba reslizumaba za zdravljenje zmerne do hude eozinofilne astme
EP3341409A1 (en)	2015-08-24	2018-07-04	Glaxosmithkline Intellectual Property (No. 2) Limited	Biopharmaceutical compositions
CA3064522A1 (en)	2017-05-26	2018-11-29	Glaxosmithkline Intellectual Property Development Limited	Biopharmaceutical compositions and related methods
US20220040154A1 (en) *	2020-08-05	2022-02-10	Knopp Biosciences, Llc	Use of dexpramipexole for the treatment of moderate to severe asthma

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB8800397D0 (en) *	1988-01-08	1988-02-10	Sandoz Ltd	Improvements in/relating to organic compounds
US5096704A (en) *	1988-11-03	1992-03-17	Schering Corporation	Method of treating eosinophilia
JPH07563B2 (ja)	1988-11-03	1995-01-11	シェリング・コーポレーション	好酸球増加症の予防または鎮静用薬剤
US5530101A (en) *	1988-12-28	1996-06-25	Protein Design Labs, Inc.	Humanized immunoglobulins
EP0533006A1 (en) *	1991-09-18	1993-03-24	F.Hoffmann-La Roche & Co. Aktiengesellschaft	Chimaeric interleukin 5-receptor/immunoglobulin polypeptides
ATE151113T1 (de)	1992-01-23	1997-04-15	Merck Patent Gmbh	Fusionsproteine von monomeren und dimeren von antikörperfragmenten
EP0625201A1 (en)	1992-02-06	1994-11-23	Schering Corporation	Design, cloning and expression of humanized monoclonal antibodies against human interleukin-5
JPH06141885A (ja)	1992-11-05	1994-05-24	Chemo Sero Therapeut Res Inst	モノクローナル抗体
AU1289795A (en)	1993-11-19	1995-06-06	Baylor College Of Medicine	Monoclonal antibodies specific for human interleukin-5
GB9412230D0 (en)	1994-06-17	1994-08-10	Celltech Ltd	Interleukin-5 specific recombiant antibodies
ES2277336T3 (es)	1994-12-23	2007-07-01	Smithkline Beecham Corporation	Antagonistas de il-5 recombinantes utiles en el tratamiento de enfermadades mediadas por il-5.
US7399837B2 (en) *	1995-12-22	2008-07-15	Smithkline Beecham Corporation	Recombinant IL-5 antagonists useful in treatment of IL-5 mediated disorders
US5683892A (en) *	1994-12-23	1997-11-04	Smithkline Beecham Corporation	DNA encoding recombinant IL-5 antagonists useful in treatment of IL-5 mediated disorders
US5783184A (en) *	1994-12-23	1998-07-21	Smithkline Beecham Corporation	Method for treatment and diagnosis of IL-5 mediated disorders
US6248723B1 (en) *	1997-06-10	2001-06-19	National Jewish Medical And Research Center	Method for treatment of inflammatory disease
KR20010031363A (ko) *	1997-10-22	2001-04-16	젠스 포니카우	진균류에 의한 점막염을 국소 치료하기 위한 항진균제의용도
WO2001012646A1 (en)	1999-08-19	2001-02-22	Smithkline Beecham Corporation	Sialoadhesin factor-1 agonist and antagonist antibodies
US20030017169A1 (en) *	2000-12-29	2003-01-23	Sidney Pestka	Controlled release systems for polymers
SI1527100T1 (sl) *	2002-03-29	2009-12-31	Schering Corp	Humana monoklonska protitelesa proti interlevkinu-5 in postopki in sestavki, ki jih obsegajo
US7339507B1 (en) *	2006-09-13	2008-03-04	Jiun-In Guo	Device for video decoding
US9333272B2 (en) *	2006-12-11	2016-05-10	Bracco Imaging Spa	Fibrin binding peptide conjugates for diagnostic and therapeutic applications
DK2152290T3 (da)	2007-04-30	2014-08-18	Glaxosmithkline Llc	Fremgangsmåder til indgivelse af anti-il-5-antistoffer
US20090035216A1 (en) *	2007-08-03	2009-02-05	Biomonitor Aps	Method for determining in vivo biopharmaceutical concentration or bioavailability
US9834600B2 (en) *	2008-03-28	2017-12-05	Glaxosmithkline Llc	Methods of treatment of eosinophilic bronchitis with an anti-IL-5 antibody
US8926631B2 (en)	2010-08-06	2015-01-06	MoMelan Technologies, Inc.	Methods for preparing a skin graft without culturing or use of biologics
SG192671A1 (en)	2011-02-09	2013-09-30	Glaxosmithkline Llc	Lyophilized formulations

2009
- 2009-03-27 US US12/935,038 patent/US9834600B2/en active Active
- 2009-03-27 EA EA201071137A patent/EA201071137A1/ru unknown
- 2009-03-27 CA CA2719786A patent/CA2719786A1/en not_active Abandoned
- 2009-03-27 AU AU2009228163A patent/AU2009228163B2/en not_active Ceased
- 2009-03-27 WO PCT/US2009/038509 patent/WO2009120927A2/en not_active Ceased
- 2009-03-27 JP JP2011502090A patent/JP5917143B2/ja active Active
- 2009-03-27 ES ES09725345.4T patent/ES2441945T3/es active Active
- 2009-03-27 BR BRPI0910854A patent/BRPI0910854A2/pt not_active IP Right Cessation
- 2009-03-27 MX MX2010010667A patent/MX2010010667A/es not_active Application Discontinuation
- 2009-03-27 KR KR1020107024046A patent/KR20100134702A/ko not_active Withdrawn
- 2009-03-27 EP EP09725345.4A patent/EP2274009B1/en not_active Revoked
- 2009-03-27 CN CN2009801176573A patent/CN102026660A/zh active Pending
2010
- 2010-09-16 ZA ZA2010/06648A patent/ZA201006648B/en unknown
- 2010-09-21 IL IL208354A patent/IL208354A0/en unknown
2014
- 2014-08-01 JP JP2014158170A patent/JP6069267B2/ja active Active
2016
- 2016-11-01 JP JP2016214438A patent/JP6457463B2/ja active Active
2017
- 2017-11-06 US US15/804,104 patent/US20180057582A1/en not_active Abandoned
2018
- 2018-12-20 JP JP2018238018A patent/JP2019065029A/ja active Pending
2019
- 2019-09-19 US US16/575,903 patent/US11325972B2/en active Active

Also Published As

Publication number	Publication date
ES2441945T3 (es)	2014-02-07
CA2719786A1 (en)	2009-10-01
US20180057582A1 (en)	2018-03-01
EP2274009A2 (en)	2011-01-19
IL208354A0 (en)	2010-12-30
JP6457463B2 (ja)	2019-01-23
US11325972B2 (en)	2022-05-10
JP2014240408A (ja)	2014-12-25
WO2009120927A2 (en)	2009-10-01
EA201071137A1 (ru)	2011-04-29
JP5917143B2 (ja)	2016-05-11
JP6069267B2 (ja)	2017-02-01
US20200071395A1 (en)	2020-03-05
AU2009228163B2 (en)	2012-08-30
EP2274009A4 (en)	2012-01-25
WO2009120927A3 (en)	2009-12-30
MX2010010667A (es)	2010-11-09
JP2019065029A (ja)	2019-04-25
EP2274009B1 (en)	2013-11-13
JP2011516422A (ja)	2011-05-26
US20110020339A1 (en)	2011-01-27
CN102026660A (zh)	2011-04-20
ZA201006648B (en)	2011-07-27
AU2009228163A1 (en)	2009-10-01
US9834600B2 (en)	2017-12-05
KR20100134702A (ko)	2010-12-23
JP2017048224A (ja)	2017-03-09

Publication	Publication Date	Title
BRPI0910854A2 (pt)	2015-10-06	métodos de tratamento
BRPI0910259A2 (pt)	2015-12-01	métodos de tratamento de inflamação
BRPI0917575A2 (pt)	2019-09-24	métodos de tratamento de talassemia
BRPI0919748A2 (pt)	2015-12-08	dipositivo de tratamento
EP2320045A4 (en)	2015-01-14	APPARATUS FOR TREATING EXHAUST GAS
BRPI0906764A2 (pt)	2015-08-18	Processos
LTPA2016041I1 (lt)	2017-01-10	Gydymo būdai panaudojant vaistus - amoniako gaudykles
EP2296593A4 (en)	2015-01-14	MEDICAL HEAD COVER
BRPI0921327A2 (pt)	2015-08-25	Combinação de herbicida-protetor
BRPI0919116A2 (pt)	2015-12-08	método
BRPI0914841A2 (pt)	2015-10-27	aparelho de massagem
BRPI0810206A2 (pt)	2014-10-21	Método de tratar câncer
IT1391555B1 (it)	2012-01-11	Apparato trattamento extracorporeo sangue
PT3412687T (pt)	2020-04-03	Métodos de tratamento de dlbcl
PT2361116T (pt)	2019-06-06	Aparelho de irradiação
FIC20240018I1 (fi)	2024-06-04	Vamoroloni
DK2313489T3 (da)	2015-06-22	Fremstillingsmetode
BRPI0919127A2 (pt)	2015-12-08	métodos para tratamento de água
DK2837348T3 (da)	2020-05-04	Kryokirurgiske fremgangsmåder
BRPI0911625A2 (pt)	2015-08-04	Métodos
DK2244628T3 (da)	2019-09-09	Patientdata-sensorapparat
DK2173831T3 (da)	2012-09-17	Brøndbehandling
BRPI0821652A2 (pt)	2017-04-04	tratamento de biocombustíveis
EP2337157A4 (en)	2014-01-08	CONNECTOR
LT3150178T (lt)	2021-08-10	Stimuliavimo aparatas

Legal Events

Date	Code	Title	Description
2015-12-08	B08F	Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]	Free format text: REFERENTE A 6A ANUIDADE.
2016-04-05	B08K	Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]	Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2344 DE 08-12-2015 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.